Drugs / DR-1021
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00544882 | Oct 2007 → Mar 2008 | — | Teva Branded Pharmaceutical Products R&D, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00362479 | Aug 2006 → Jul 2007 | — | Duramed Research | Completed | No outcome recorded |
| Phase 3 | NCT00326404 | May 2006 → May 2008 | — | The Hospital for Sick Children | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DR-1021 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00544882 ↗ |
| Known as | Desogestrel-Ethinyl Estradiol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00326404 ↗ |
| Route | Oral | “6 months of oral contraceptive therapy with DR-1021” NCT00362479 ↗ |